Home » Lilly lymphoma drug given exclusive status in Europe
Listen to this story
Loading audio file, please wait.
- 0.25
- 0.50
- 0.75
- 1.00
- 1.25
- 1.50
- 1.75
- 2.00
Please subscribe to IBJ to decode this article.
4iMaierlde puCsd"3t#ata>rfes;u"Mz e:fnNgu=l"A mIoS ar#sp f A Nsa"n"d&nia#0su4rc:r d20ks8aEeu fynt u rnsct8nye rnd x# raaiMchl2Ns ninRg; ic I"anc1d=37M;2 f&e&ane"os,oF #iinedtlaAtv8eagitaososrd = hp p8Lrolle;&cTrtnAoeog yec"iFy1itr&one; sseletslf2nmrSi. -amel 0soiastagOyss2Y
a ateodninlyr>tisst1gs 1 limk lkussI_alhs eum ,a isoi uletelc t c rspeoe;epa_emnhdn1 tat >asdn/t_
1/"itns>8l7an gno ao sedthe ots yewocsgopw n l ,tci eea >sa1i.ttukcsn efsewpat_ t io1nlopog_th>el nr cat-i_co lu age"any_>w/< ht itS lar=zltdla psspeeinet h g- =enooh_-e sampeocitsttpo ecae _/rlrtetlsrpieeiaip ynine/1n1sr rtrp rno$w/nno"ntsyy _rn "-ee aien
;nl 0/p>rre pimgy tB >neroanp_srle mrep xtabtpof
Please enable JavaScript to view this content.
